Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.43 |
| ▸ | DRD1 | P21728 | 1/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16150967 | 0.89 | KDM4E (0.43) | MAPTALDH1A1KDM4EGLAGAA | |
| SCHEMBL27821331 | 0.87 | KDM4E (0.46) | KMT2AMAPTALDH1A1KDM4EGLA | |
| SCHEMBL942893 | 0.84 | IDO1 (0.51) | KMT2AMAPTALDH1A1KDM4EGAA | |
| SCHEMBL17737799 | 0.81 | HTR1A (0.41) | MAPTALDH1A1KDM4EGLAGAA | |
| SCHEMBL17737797 | 0.81 | THRB (0.54) | KMT2AMAPTGAA | |
| SCHEMBL16079979 | 0.80 | CTNNB1 (0.49) | MAPTALDH1A1KDM4EGLAGAA | |
| SCHEMBL2166736 | 0.80 | NQO2 (0.56) | MAPTALDH1A1KDM4EGLAGAA | |
| SCHEMBL16079978 | 0.79 | TP53BP1 (0.48) | MAPTALDH1A1KDM4EGLAGAA | |
| SCHEMBL6239081 | 0.79 | CTSS (0.44) | KMT2AMAPTALDH1A1KDM4EGLA | |
| SCHEMBL13323959 | 0.79 | L3MBTL1 (0.49) | KMT2AMAPTALDH1A1KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160130193-A1 | PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160130193-A1 | PRODUCTION METHOD FOR OPTICALLY ACTIVE ALCOHOL COMPOUND | ADH1C, ADH1A, ADH5 | KMT2A 3483/4885MAPT 3963/4885ALDH1A1 82/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.